SEC Form 4 · accession 0001437749-15-011242
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James G. Atkinson
Officer — CBO & President
Period of report
May 12, 2015
Accepted (ET)
May 28, 2015 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common StockF1 | $0.53 | May 12, 2015 | A | 217,733 | A | May 12, 2015 | May 12, 2025 | Common Stock, no par value | 217,733 | 217,733 | D |
Explanation of responses
- F1Pursuant to a certain consulting agreement by and between the Issuer and the reporting person, on May 12, 2015, the reporting person received a ten-year warrant to purchase 217,733 shares of common stock of the Issuer at a per share price of $0.53.